Full Text
PDB31 A LIFETIME MODELLED ECONOMIC EVALUATION COMPARING PIOGLITAZONE AND ROSIGLITAZONE FORTHE TREATMENT OF TYPE-2 DIABETES MELLITUS IN THE UK

Abstract

Authors

D Tilden S Mariz A Diamantopoulos G O'Bryan-Tear

Back to Volume 8, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×